Scientific and patient care evidence to change susceptibility breakpoints for first-line anti-tuberculosis drugs
- PMID: 22507940
- DOI: 10.5588/ijtld.11.0850
Scientific and patient care evidence to change susceptibility breakpoints for first-line anti-tuberculosis drugs
Comment on
-
Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis.Int J Tuberc Lung Dis. 2012 Feb;16(2):216-20. doi: 10.5588/ijtld.11.0178. Int J Tuberc Lung Dis. 2012. PMID: 22137551
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources